Paper Review Records
全部论文审稿周期
5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
95
天
Human Abuse Potential of Single Oral Doses of Sunobinop, a Novel, Highly Potent, and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors
作者
Stephen C. Harris; Alessandra Cipriano; Garth T. Whiteside; Kerri A. Schoedel; Ellie He; Manjunath S. Shet; Glen Apseloff展开收起
作者单位
1. Imbrium Therapeutics L.P., Stamford, CT; 2. Altreos Research Partners Inc., Toronto, Canada; 3. Ohio Clinical Trials Inc., Columbus, OH展开收起
105
天
108
天
Effects of Adjunctive Brexpiprazole in Major Depressive Disorder Analyzed by Baseline Anxiety Level
作者
François Therrien; Caroline Ward; Zhen Zhang; Pratap Chokka; Jeffrey Habert; Zahinoor Ismail; Roger S. McIntyre; A. Marilise Marrache展开收起
作者单位
1. Otsuka Canada Pharmaceutical Inc., Saint-Laurent, Canada; 2. Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 3. Chokka Center for Integrative Health, Edmonton, Canada; 4. Department of Psychiatry, University of Alberta, Edmonton, Canada; 5. Department of Family and Community Medicine, University of Toronto, Toronto, Canada; 6. Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences, Hotchkiss Brain Institute and O’Brien Institute for Public Health, University of Calgary, Calgary, Canada; 7. Faculty of Health and Life Sciences, NIHR Exeter Biomedical Research Unit, University of Exeter, Exeter, United Kingdom; 8. Department of Psychiatry, University of Toronto, Toronto, Canada; 9. Lundbeck Canada Inc., Saint-Laurent, Canada展开收起
121
天
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder
作者
Lori L. Davis; Saloni Behl; Daniel Lee; Hui Zeng; Taisa Skubiak; Shelley Weaver; Nanco Hefting; Klaus Groes Larsen; Mary Hobart展开收起
作者单位
1. Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL; 2. Clinical Development, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 3. Biostatistics, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 4. Clinical Management, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ; 5. Clinical Development, H. Lundbeck A/S, Valby, Denmark; 6. Biostatistics, H. Lundbeck A/S, Valby, Denmark; 7. R&D Evidence, Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ展开收起
116
天
Gender Differences in Psychotropic Medication Use
作者
Edith J. Liemburg; Klaas J. Wardenaar; Sanne Krol; Maaike M. van Veen; Bennard Doornbos; Arne Risselada; Danielle C. Cath展开收起
作者单位
1. GGZ Friesland, Department of Research, Leeuwarden; 2. Department of Psychiatry, Rob Giel Research Center, University of Groningen, University Medical Center Groningen; 3. Department of Child and Family Welfare, Faculty of Behavioural and Social Sciences, University of Groningen, Groningen; 4. GGZ Drenthe Mental Health Services, Assen, The Netherlands; 5. Lentis Mental Health Organization, Lentis Research, Groningen; 6. Department of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天